The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Seeking 4-6 startups to participate in the ILP Beijing Virtual Symposium on November 5, 2020.
Austin Che Founder, Ginkgo Bioworks
Fujitsu Limited(“Fujitsu”) would like to solicit applications from interested members of the industry and academia to test the quantum simulator on novel problems and applications.
Join to hear from MIT faculty and MIT Startup Exchange entrepreneurs to learn how to navigate this new era with management best practices.